跳至主要内容
临床试验/ACTRN12613000031763
ACTRN12613000031763尚未招募4 期

Statin therapy in Ischemia-Reperfusion Injury: A randomised trial to evaluate the effect of high dose rosuvastatin on myocardial infarct size post coronary artery bypass grafting (CABG).

South Australian Health and Medical Research Institute0 个研究点目标入组 100 人开始时间: 2013年1月11日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Adult patients who are scheduled to undergo elective on-pump CABG with or without aortic valve replacement.
  • For patients on statins pre-CABG, statin dose must be unchanged for 30 days pre-CABG.

排除标准

  • Standard CMR contra-indications
  • Known intolerance to statins
  • Renal (eGFR <45mls/min) and hepatic impairment
  • Emergency CABG
  • Mitral or tricuspid valve repair or replacement
  • Off-pump CABG
  • Patients who are Filipino, Chinese, Japanese, Korean or Vietnamese
  • Patients on cyclosporine, gemfibrozil or fisidic acid
  • Patients who are already on rosuvastatin or atorvastatin 80 mgs pre-CABG
  • Re-do surgery

研究者

相似试验

Statin Therapy in Ischemia-Reperfusion Injury during... | 临床试验